First Time Loading...

Organogenesis Holdings Inc
NASDAQ:ORGO

Watchlist Manager
Organogenesis Holdings Inc Logo
Organogenesis Holdings Inc
NASDAQ:ORGO
Watchlist
Price: 3.03 USD 32.89% Market Closed
Updated: May 12, 2024
Section:
 

Relative Value

The Relative Value of one ORGO stock under the Base Case scenario is 6.11 USD. Compared to the current market price of 3.03 USD, Organogenesis Holdings Inc is Undervalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ORGO Relative Value
Base Case
6.11 USD
Undervaluation 50%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
92
vs Industry
88
Median 3Y
1.1
Median 5Y
1.5
Industry
8.2
Forward
0.9
More Details
80.5
P/E
P/E
Price to Earnings
80.5
vs History
12
vs Industry
2
Median 3Y
23.6
Median 5Y
12.1
Industry
27.4
Forward
-221.8
More Details
12.9
P/OCF
P/OCF
Price to OCF
12.9
vs History
63
vs Industry
11
Median 3Y
14.9
Median 5Y
12.4
Industry
24.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
2
Median 3Y
-24.5
Median 5Y
-14.7
Industry
23
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
95
vs Industry
55
Median 3Y
1.9
Median 5Y
6.2
Industry
2.6
More Details
0.8
EV/S
EV/S
Enterprise Value to Sales
0.8
vs History
92
vs Industry
80
Median 3Y
1
Median 5Y
1.6
Industry
7.5
Forward
0.8
More Details
1.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.1
vs History
92
vs Industry
76
Median 3Y
1.3
Median 5Y
2.4
Industry
9.3
More Details
12.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.8
vs History
55
vs Industry
10
Median 3Y
11.7
Median 5Y
10.3
Industry
4.3
Forward
18.6
More Details
28.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
28.5
vs History
34
vs Industry
7
Median 3Y
16.8
Median 5Y
13.9
Industry
4.2
Forward
-490.7
More Details
11.5
EV/OCF
EV/OCF
Enterprise Value to OCF
11.5
vs History
63
vs Industry
12
Median 3Y
13.7
Median 5Y
11.1
Industry
5.9
More Details
54.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
54.4
vs History
23
vs Industry
4
Median 3Y
31
Median 5Y
-7.6
Industry
3.3
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
93
vs Industry
62
Median 3Y
1.4
Median 5Y
3.1
Industry
4.9
More Details

Multiples Across Competitors

ORGO Competitors Multiples
Organogenesis Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Organogenesis Holdings Inc
NASDAQ:ORGO
397.9m USD 0.9 80.5 12.8 28.5
US
Abbvie Inc
NYSE:ABBV
283.9B USD 5.2 58.9 12.8 19.5
US
Amgen Inc
NASDAQ:AMGN
166.4B USD 5.6 44.2 18.6 30.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
108.9B USD 11 30.1 24.2 25.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
107.3B USD 8.2 27.8 22.5 24.9
AU
CSL Ltd
ASX:CSL
134.9B AUD 6.3 36 21.8 27
US
Gilead Sciences Inc
NASDAQ:GILD
82.2B USD 3 169.8 6.8 8.9
US
Moderna Inc
NASDAQ:MRNA
44.9B USD 8.7 -7.5 -8.1 -7.2
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
32.3B USD 3.3 27.6 14.1 17.7
KR
Celltrion Inc
KRX:068270
40T KRW 18.4 74.6 45.6 62.9

See Also

Summary
ORGO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORGO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORGO stock valuation using valuation multiples.
Wall Street Estimates
ORGO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORGO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.